Recent Articles

• 
  Medical / Research

  Vets Propose Korean Standard for Small Dog Bile Duct Surgery

  The joint research team that has secured publication in JSAP with the development of a small-breed dog-tailored bile duct surgery technique. (From left) Veterinarians Myung Hyeon-uk, Eom Tae-heum, and Son Dong-joo Gallbladder mucocele and the resulting extrahepatic biliary obstruction (EHBO) are lif

  2026.04.01
• 
  Global Expansion

  From Songdo to World: Next-Gen Vaccine, Bio Push

  Panoramic view of SK bioscience’s Global R&PD Center in Songdo. Provided by SK bioscience SK bioscience is accelerating its mid- to long-term growth strategy based on global collaboration. In January, the company relocated its headquarters and research institute to the Songdo R&PD Center, establ

  2026.04.01
• 
  Biopharma

  AI-Driven Obesity Drugs Spur Next K-Bio Battle

  Getty Images Bank 《Domestic pharmaceutical and bio companies are demonstrating their research and development capabilities by continuously achieving results in new drug candidate discovery, clinical progress, and large-scale technology transfer deals. In particular, they are rapidly building R&D cap

  2026.04.01
• 
  DTx / Platform

  ‘Medical OS’ Era Begins: Beyond EMR to AI Platform

  GC Mediai CEO Kim Jin-tae announces the company’s new name at a corporate briefing on March 20. Courtesy of GC Mediai GC Mediai (CEO Kim Jin-tae, formerly Ubcare) is accelerating its transition into a “medical OS (operating system)” company that leads an artificial intelligence (AI)-based healthcare

  2026.04.01
• 
  Biopharma

  Lekma Emerges as Global Lung Cancer Game Changer

  Yuhan R&D Center. Provided by Yuhan Corporation Dr. Yu Il-han founded Yuhan Corporation in 1926 with the corporate philosophy of “Let us create the best products to help the nation and compatriots.” A century later, that spirit lives on in “Lecraza” (ingredient name: lazertinib), a treatment for non

  2026.04.01
• 
  Aesthetic

  Cosmetics, Drugs, Devices: Aesthetic Lineup Expands

  Panoramic view of Huons Group headquarters building. Provided by Huons Meditec Huons Group affiliate Huons Meditec is moving to solidify its position in the aesthetic market based on the expansion of its aesthetic lineup and academic marketing targeting medical professionals. With a multilayered por

  2026.04.01
• 
  Biopharma

  Korea’s First Hypertension Drug Kanarb Marks 15 Years, Eyes Global Expansion

  At the symposium marking the 15th anniversary of Kanarb’s launch, Boryung CEO Kim Jeong-gyun gives a presentation. Provided by Boryung Corp. Boryung Corp. (CEO Kim Jeong-gyun) announced that it held a commemorative symposium on the 5th of last month to mark the 15th anniversary of the launch of its

  2026.04.01
• 
  Medical / Drug Development

  GC Cell Files Patent for Solid Tumor CAR-NK Therapy

  GC Cell (GC셀) announced on the 31st that it has filed a patent application for technology related to chimeric antigen receptor natural killer cells (CAR-NK), an immune cell therapy for the treatment of solid tumors.This patent is based on GC Cell’s proprietary CAR-NK platform. CAR-NK is a next-gener

  2026.03.31
• 
  AI Healthcare

  SCL Science Uses AI Protein Model to Find Tumor Antigens

  At the Spring Academic Conference of the Korean Association of Clinical Immunologists held on the 26th, Choi Jung-gyun, CEO of Neogen Logic, is explaining the anti-cancer vaccine AI model “Deep Neo” and the latest research achievements. Provided by SCL Science SCL Science has presented an AI-based a

  2026.03.30
• 
  AI Healthcare

  ‘Unused Medical Data’ Era Ends as AI Unlocks Use

  If a patient’s medical history and current medications can be checked immediately in an emergency, the speed of treatment can change significantly.The Korea Health Information Service (KHIS) is launching “Artificial Intelligence Transformation (AX)” to link medical data, which has so far remained in

  2026.03.30